Reverse Remodeling and Genetics: A Review Based on a Clinical Case Description that Challenges Current Evidence and Logic
ABC Heart Fail Cardiomyop · 31.12.2025 · 5 (4)
DOI: 10.36660/abchf.20250026i ↗Kurz gefasst
Fachartikel in der Zeitschrift ABC Heart Fail Cardiomyop, erschienen am 31.12.2025. Verfasst von Helena Garcia Betinardi Bernardi und 5 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Cardiac remodeling, present in heart failure (HF), is a compensatory biological process following an initial myocardial injury that gradually becomes maladaptive, leading to clinical deterioration and chronic HF. Reverse remodeling (RR), which has been increasingly addressed, occurs when the geometry and/or function of the left ventricle recover in response to treatment, approaching normal cardiac structure. RR is associated with a better prognosis. Factors associated with RR include female sex, non-ischemic etiology, mild to moderate HF, lower fibrotic burden, elevated [...]
Zitieren
APA
Bernardi, H. G. B., Furquim, S., Hames, R. L., Koroishi, J. H. Y., Pinheiro, J. A., & Martins, S. K. (2025). Reverse Remodeling and Genetics: A Review Based on a Clinical Case Description that Challenges Current Evidence and Logic. ABC Heart Fail Cardiomyop, 5(4). https://doi.org/10.36660/abchf.20250026i
Vancouver
Bernardi HGB, Furquim S, Hames RL, Koroishi JHY, Pinheiro JA, Martins SK. Reverse Remodeling and Genetics: A Review Based on a Clinical Case Description that Challenges Current Evidence and Logic. ABC Heart Fail Cardiomyop. 2025;5(4). doi:10.36660/abchf.20250026i
BibTeX
@article{Bernardi2025,
author = {Bernardi, Helena Garcia Betinardi and Furquim, Silas and Hames, Renata Lopes and Koroishi, Jorge Henrique Yoschimoto and Pinheiro, Jairo Alves and Martins, Stevan Krieger},
title = {Reverse Remodeling and Genetics: A Review Based on a Clinical Case Description that Challenges Current Evidence and Logic},
journal = {ABC Heart Fail Cardiomyop},
year = {2025},
volume = {5},
number = {4},
doi = {10.36660/abchf.20250026i}
}
EUVIMED